Status:
COMPLETED
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
Lead Sponsor:
AstraZeneca
Conditions:
GERD
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL)...
Eligibility Criteria
Inclusion
- Female and/or male aged \> 18 years
- Diagnosis of GERD confirmed
- Prescription of GERD treatment or already receiving GERD treatment
Exclusion
- Any symptom suggesting a need for further investigation
- Previous participation in the present study
- Current participation in a clinical study or participation in a clinical study during the last 30 days
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00884247
Start Date
April 1 2009
End Date
June 1 2009
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Hälsocenter, Södertälje, Sweden